NSEOutcome of Board MeetingM&A8 Jul 2026
Iris Clothings Limited
Outcome of Board Meeting
Iris Clothings Limited has informed the Exchange regarding the outcome of its Board meeting, where it approved the acquisition of 51% of Infinia Lifestyle Private Limited's equity shares for a total purchase consideration of INR 57.12 crore. The acquisition will be made partly by cash and partly by issuing 77.08 lakh equity shares of Iris Clothings Limited at a price of INR 41.67 per share. The company also approved the issuance of up to 77.08 lakh equity shares on a preferential basis for consideration other than cash, to discharge part of the purchase consideration.
NSEOutcome of Board Meeting▲ PositiveM&A8 Jul 2026
Natco Pharma Limited
Outcome of Board Meeting
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026, where the Board of Directors approved to acquire additional shareholding in Adcock Ingram Holdings Proprietary Limited, increasing its stake from 35.75% to 49%. The acquisition valued at ₹ 1,069 crores will take NATCO's shareholding in Adcock Ingram from 35.75% to 49%. Adcock Ingram has delivered a topline of US$ 423 million with an EBITDA of ~US$ 59 million for the period ending 9 months on March 31, 2026.
NSEGeneral UpdatesM&A8 Jul 2026
JB Chemicals & Pharmaceuticals Limited
General Updates
JB Chemicals & Pharmaceuticals Limited has informed the Exchange about the effective date of the Scheme of Amalgamation with Torrent Pharmaceuticals Limited, as approved by the Hon'ble National Company Law Tribunal, Ahmedabad Bench.
NSEPress Release▲ PositiveM&A8 Jul 2026
Leela Palaces Hotels & Resorts Limited
Press Release
The Leela Palaces, Hotels and Resorts has been ranked the #2 Best Hotel Brand in the World in the Travel + Leisure World's Best Awards 2026 Survey.
NSEAmendment to AOA/MOAM&A8 Jul 2026
Torrent Pharmaceuticals Limited
Amendment to AOA/MOA
Torrent Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, following the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited, which has become effective on 8th July, 2026.
NSEGeneral UpdatesM&A8 Jul 2026
Torrent Pharmaceuticals Limited
General Updates
Torrent Pharmaceuticals Limited has informed the Exchange about the effectiveness of the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited, as approved by the Hon'ble National Company Law Tribunal, Ahmedabad Bench.
NSEPress Release▲ PositiveM&A8 Jul 2026
Marksans Pharma Limited
Press Release
Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a German-based pharmaceutical company. The acquisition will enable Marksans to use ABCnow's front-end sales and marketing infrastructure for marketing its products in the European Union.
NSEUpdatesM&A7 Jul 2026
Nazara Technologies Limited
Updates
Nazara Technologies Limited has informed the Exchange regarding the withdrawal of the Scheme of Amalgamation of Paper Boat Apps Private Limited, a wholly owned subsidiary, due to changes in restructuring plans. The Hon'ble National Company Law Tribunal, Mumbai Bench, has allowed the application seeking withdrawal of the Scheme.
NSEPress Release▲ PositiveM&A7 Jul 2026
Restaurant Brands Asia Limited
Press Release
Restaurant Brands Asia Limited (RBA) has been acquired by Inspira Global, with a total investment of ~INR 2235 crores. Inspira Global owns 41.78% of RBA and has the option to increase its stake to 48.04% by infusing further INR 450 Cr. The acquisition marks the beginning of a new chapter for RBA, with a focus on expanding its restaurant network, enhancing customer experience, and creating sustainable long-term value for stakeholders.
NSEGeneral UpdatesM&A7 Jul 2026
PVP Ventures Limited
General Updates
PVP Ventures Limited has completed the acquisition of an additional 4,263 equity shares of 7 Med India Private Limited, increasing its shareholding to 41.23% of the target company's total paid-up share capital. The acquisition is part of the company's strategic investment in the healthcare sector.
NSERecord DateM&A7 Jul 2026
JB Chemicals & Pharmaceuticals Limited
Record Date
JB Chemicals & Pharmaceuticals Limited has announced a record date of 17-Jul-2026 for the purpose of a merger with Torrent Pharmaceuticals Limited.
NSERecord DateM&A7 Jul 2026
Torrent Pharmaceuticals Limited
Record Date
Torrent Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of OT is 17-Jul-2026, in relation to the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited.
NSEGeneral UpdatesM&A7 Jul 2026
DS Kulkarni Developers Limited
General Updates
The board of directors of D S Kulkarni Developers Limited has approved the acquisition of 100% equity stake in Moonbrick Realty Private Limited, a company incorporated in Pune, Maharashtra, to make it a wholly owned subsidiary.
NSEOutcome of Board MeetingM&A7 Jul 2026
DS Kulkarni Developers Limited
Outcome of Board Meeting
DS Kulkarni Developers Limited has informed the Exchange regarding Outcome of Board Meeting held on July 07, 2026, where the board of directors approved the acquisition of 100% equity stakes of M/s. Moonbrick Realty Private Limited, a company incorporated in Pune, Maharashtra, to make it a wholly owned subsidiary of DSK Kulkarni Developers Limited. The board also approved the appointment of CS Rishika Verma as the Company Secretary & Compliance Officer of the Company.
NSEDemergerM&A7 Jul 2026
Religare Enterprises Limited
Demerger
Religare Enterprises Limited has received observation letters with no objection from National Stock Exchange of India Limited and no adverse observations from BSE Limited in relation to the Scheme of Arrangement between Religare Enterprises Limited and Religare Finvest Limited.
NSEGeneral UpdatesM&A7 Jul 2026
Torrent Pharmaceuticals Limited
General Updates
Torrent Pharmaceuticals Limited has informed the Exchange about the receipt of a certified true copy of the Order passed by the National Company Law Tribunal, Ahmedabad Bench, regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders.
NSEGeneral UpdatesM&A7 Jul 2026
JB Chemicals & Pharmaceuticals Limited
General Updates
JB Chemicals & Pharmaceuticals Limited has informed the Exchange about receiving a certified true copy of the Order passed by National Company Law Tribunal, Ahmedabad Bench regarding the Scheme of Amalgamation with Torrent Pharmaceuticals Limited.
NSEGeneral UpdatesM&A7 Jul 2026
Arvind Limited
General Updates
Arvind Limited has informed the Exchange about the acquisition of 100% stake of Arvind Atelier UK Limited, a company incorporated in the United Kingdom, by its subsidiary Arvind Atelier FZC. The acquisition will result in Arvind Atelier UK Limited becoming a step-down subsidiary of Arvind Limited.
NSEUpdatesM&A7 Jul 2026
Jagsonpal Pharmaceuticals Limited
Updates
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding the completion of acquisition of 69.77% stake in Aequitas Healthcare Private Limited, making Aequitas a subsidiary of Jagsonpal.
NSEPress Release▲ PositiveM&A7 Jul 2026
Adani Enterprises Limited
Press Release
Adani Enterprises Limited has informed the Exchange regarding a press release dated July 07, 2026, titled "Adani Enterprises Kutch Copper Limited Achieves London Metal Exchange Brand Registration for Adani Copper Grade-A Cathodes".